A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues

2013 • 47,043 citations

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

1988 • 6,107 citations

Searching for Peptide Ligands with an Epitope Library

1990 • 2,080 citations

The Accuracy of Reverse Transcriptase from HIV-1

1988 • 982 citations

Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant

1990 • 665 citations

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

1988 • 540 citations

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera

1990 • 416 citations

Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-1

1990 • 358 citations

Genomic Diversity of Human T-Lymphotropic Virus Type III (HTLV-III)

1985 • 249 citations

Induction of anti-HIV neutralizing antibodies by synthetic peptides.

1986 • 237 citations

Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees

1990 • 230 citations

Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein

1993 • 225 citations

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

1989 • 222 citations

Characterization of HIV-1 neutralization escape mutants

1989 • 220 citations

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene

1988 • 186 citations

A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS

1988 • 183 citations

Genetic recombination of human immunodeficiency virus

1989 • 180 citations

Anti-HIV and Anti-Anti-MHC Antibodies in Alloimmune and Autoimmune Mice

1991 • 140 citations

Tumor promoter, TPA, enhances replication of HTLV-III/LAV

1986 • 133 citations

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.

1992 • 120 citations

Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro

1991 • 120 citations

Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.

1990 • 120 citations

Retroviral recombination during reverse transcription.

1990 • 116 citations

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

1988 • 115 citations

In vitro generation of an HTLV-III variant by neutralizing antibody.

1986 • 79 citations

Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region.

1990 • 52 citations

Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines.

1988 • 51 citations

Discrete regions of HIV-1 gp41 defined by syncytia-inhibiting affinity-purified human antibodies

1993 • 32 citations

Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses.

1991 • 27 citations

Electroporative gene transfer (electrotransfection): A method for strain improvement of animal cells

1987 • 5 citations

Cited By (0)

Loading...